PULSION Medical Systems SE Cash Flow Conversion Efficiency

Latest as of December 2017: 0.160x

PULSION Medical Systems SE cash flow conversion efficiency. Based on the latest financial reports, PULSION Medical Systems SE (PUS) has a cash flow conversion efficiency ratio of 0.160x as of December 2017. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€3.30 Million ≈ $3.86 Million USD) by net assets (€20.60 Million ≈ $24.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of PULSION Medical Systems SE (2003–2017)

Cash flow conversion efficiency of PULSION Medical Systems SE from 2003 to 2017. This chart illustrates how PULSION Medical Systems SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest PULSION Medical Systems SE stock price today for real-time trading data and today's change.

PULSION Medical Systems SE Cash Flow Conversion Ratio Explained

PULSION Medical Systems SE cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

PULSION Medical Systems SE Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PULSION Medical Systems SE ranked by their cash flow conversion efficiency. Also see PUS market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
AG Mortgage Investment Trust Inc NYSE:MITT	0.037x
Hi-Clearance TWO:1788	0.036x
Polytronics Technology Corp TW:6224	0.010x
LWSABAH KLSE:5328	N/A
Agilyx AS OL:AGLX	-0.077x
Honma Golf Limited F:HF5	0.008x
Korea Air Svc KO:005430	0.068x
Plano & Plano Desenvolvimento Imobiliário S.A SA:PLPL3	-0.118x

Annual Cash Flow Conversion Efficiency for PULSION Medical Systems SE (2003–2017)

The table below shows the annual cash flow conversion efficiency of PULSION Medical Systems SE from 2003 to 2017. Review PUS cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2017-12-31	€20.60 Million ≈ $24.08 Million	€3.30 Million ≈ $3.86 Million	0.160x	-58.51%
2016-12-31	€20.60 Million ≈ $24.08 Million	€7.95 Million ≈ $9.30 Million	0.386x	+2.01%
2015-12-31	€20.60 Million ≈ $24.08 Million	€7.80 Million ≈ $9.11 Million	0.378x	+17.18%
2013-12-31	€17.59 Million ≈ $20.56 Million	€5.68 Million ≈ $6.64 Million	0.323x	-14.55%
2012-12-31	€23.84 Million ≈ $27.87 Million	€9.01 Million ≈ $10.53 Million	0.378x	+19.36%
2011-12-31	€21.10 Million ≈ $24.66 Million	€6.68 Million ≈ $7.81 Million	0.317x	-19.62%
2010-12-31	€16.56 Million ≈ $19.36 Million	€6.52 Million ≈ $7.63 Million	0.394x	+68.19%
2009-12-31	€16.98 Million ≈ $19.85 Million	€3.98 Million ≈ $4.65 Million	0.234x	+285.75%
2008-12-31	€16.24 Million ≈ $18.99 Million	€986.00K ≈ $1.15 Million	0.061x	-77.22%
2007-12-31	€17.05 Million ≈ $19.94 Million	€4.55 Million ≈ $5.31 Million	0.267x	+21.43%
2006-12-31	€14.63 Million ≈ $17.10 Million	€3.21 Million ≈ $3.75 Million	0.220x	-24.20%
2005-12-31	€11.25 Million ≈ $13.16 Million	€3.26 Million ≈ $3.81 Million	0.290x	+20.71%
2004-12-31	€9.20 Million ≈ $10.76 Million	€2.21 Million ≈ $2.58 Million	0.240x	+139.46%
2003-12-31	€8.31 Million ≈ $9.72 Million	€833.00K ≈ $973.86K	0.100x	--

About PULSION Medical Systems SE

MU:PUS Germany Medical Devices

Market Cap

$208.21 Million

€178.09 Million EUR

Market Cap Rank

#16795 Global

#1590 in Germany

Share Price

€21.60

Change (1 day)

+0.00%

52-Week Range

€21.00 - €21.60

All Time High

€25.25